ARCHIVES

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting

October 26, 2007

Nobel In Chemistry For Work Linking Carbon Atoms

October 8, 2010

Nine Saturation Program Planning Contracts Approved

May 9, 1975

Congress Orders Programs In Nutrition Research; Cancer Act Extension Beefs Up NCI Chief’s Authority

July 12, 1974

Michelle Le Beau named director of University of Chicago Cancer Research Center.

May 7, 2004

New Chemoprevention Program Will Get “Whatever Money It Need;” Clinical Trials In New Division

July 25, 1980